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Inefficient combustion processes result in
incomplete combustion and can emit com-
plex mixtures of organic pollutants, metals,
and ﬁne particles due to incomplete combus-
tion. Although this concept generally brings
to mind the image of a tall smokestack spew-
ing a dark plume, combustion sources are
greatly varied and quite often not related to
industrial facilities. Combustion processes
include manufacturing processes, residential
fuel use for heating and cooking, and open
burning, as well as the diverse internal com-
bustion engines found in jets, construction
equipment, cars and trucks, lawnmowers, and
so on. Not only are combustion processes
diverse, but the by-products emitted (deﬁned
as products other than the most thermody-
namically stable reaction products, i.e., car-
bon dioxide and water) vary with process
efﬁciency and fuel type.
Indoor and outdoor environments are
widely contaminated by complex mixtures of
combustion-derived gases and particles (1), and
these pollutants create global human and envi-
ronmental health problems. Because combus-
tion sources are found worldwide, it is not only
the residents of industrial cities in developed
nations that face the environmental health risks
from exposure to combustion by-products.
Moreover, by-products of combustion
processes have potential for wide-ranging
impacts, not only on human health but on
entire ecosystems and the global climate.
These issues were addressed at the Seventh
International Congress on Combustion By-
Products (held 4–6 June 2001 in Research
Triangle Park, NC). This congress included a
diverse group of multidisciplinary researchers
and practitioners who discussed recent devel-
opments and future goals in the control of
combustion by-products and their effects of
exposure on human and ecologic health. In
this article we summarize the principal ﬁnd-
ings and recommendations for research focus
and direction. A key need is the development
of technologies to provide safe, clean, and
efficient energy systems, with the ultimate
goal of translating discoveries to public health
intervention strategies.
Combustion By-Products:
Impacts on a Global Scale
Environmental health policy has primarily
focused on issues that are considered global in
scale. Current policies emphasize environmen-
tal issues that are global in the sense that the
environmental impact is the result of world-
wide emissions or atmospheric formation of a
single pollutant or small identiﬁable group of
pollutants. For example, combustion-generated
hydrocarbons and nitrogen oxides react in the
atmosphere in the presence of heat and sunlight
to form harmful concentrations of ground-level
ozone. But it is not only cities with high num-
bers of industrial facilities or cars that are sub-
ject to high ozone levels, as winds carry
nitrogen oxides (NOx) emissions hundreds of
miles away from their original sources (2).
Global climate change. With regard to
global warming, the surface temperature of
Earth has increased approximately 1.2°C since
1850 (3), with 0.5°C of the change occurring
since 1978 (4). Predictions for future changes
in our climate vary, but most scenarios predict
a steady increase in global temperature
throughout the twenty-ﬁrst century (5). The
magnitude of the impacts of global warming on
human health, environmental health, and
national economies remains unknown. Climate
change will likely cause more economic damage
in developed countries and more human health
damage in less developed countries (6).
There is a growing consensus among
many scientists that global warming is, at least
in part, the result of increasing levels of
anthropogenic greenhouse gases [carbon diox-
ide (CO2), nitrous oxide (N2O), methane
(CH4), chlorofluorocarbon (CFC)] and tro-
pospheric aerosols (7). Industrial, energy-pro-
ducing, and residential combustion processes
contribute significantly to global levels of
greenhouse gases (GHG). Burning of fossil
Address correspondence to W.A. Suk, Division of
Extramural Research and Training, National
Institute of Environmental Health Sciences, PO Box
12233, Research Triangle Park, NC 27709 USA.
Telephone: (919) 541-0797. Fax: (919) 541-2843.
E-mail: suk@niehs.nih.gov
The steering committee and participants of the
Seventh International Congress on Combustion By-
Products dedicate the congress and this article to
their colleague, Glen R. Cass, who died 30 July
2001. We salute his integrity, his contribution to the
field of atmospheric sciences, and his professional
achievements.
The Seventh International Congress on Combustion
By-Products was co-sponsored by the NIEHS/U.S.
EPA Superfund Basic Research Program, the National
Science Foundation, Coalition for Responsible Waste
Incineration, and Sandia National Laboratory.
Received 5 November 2001; accepted 15 April 2002.
Incomplete combustion processes can emit organic pollutants, metals, and fine particles.
Combustion by-products represent global human and environmental health challenges that are
relevant not only in heavily industrialized nations, but also in developing nations where up to
90% of rural households rely on unprocessed biomass fuels for cooking, warmth, and light. These
issues were addressed at the Seventh International Congress on Combustion By-Products, which
convened 4–6 June 2001 in Research Triangle Park, North Carolina. This congress included a
diverse group of multidisciplinary researchers and practitioners who discussed recent develop-
ments and future goals in the control of combustion by-products and their effects of exposure on
human and ecologic health. Participants recommended that interdisciplinary, coordinated research
efforts should be focused to capitalize on the important potential synergisms between efforts to
reduce the adverse human health effects linked to exposures to combustion by-products and
broader efforts to reduce greenhouse gas emissions and save energy through efﬁciency. In this arti-
cle we summarize the principal findings and recommendations for research focus and direction.
Key words: combustion by-products, ﬁne particles, genetic susceptibility, lung pathobiology, met-
als, polychlorinated dibenzodioxins, polychlorinated dibenzofurans, public health. Environ Health
Perspect 110:1155–1162 (2002). [Online 26 September 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1155-1162avakian/abstract.html
Workshop Summariesfuels is the major source of CO2 emissions, as
well as a major source of aerosols, especially
black carbon, organic aerosols, and sulfates
(5). Combustion processes are also major
emitters of NOx and sulfur oxides (SOx) (8).
Human health effects. The effects of com-
bustion by-product pollution on human health
are real and need to be addressed by sound sci-
entiﬁc research. The practical beneﬁts of efforts
to reduce pollutant emissions from combus-
tion processes would be realized immediately
(9). Environmental health researchers have
estimated that reducing emissions from older
coal-fired power plants in the United States
could provide substantial benefits to public
health, including the avoidance of 18,700
deaths, 3 million lost work days, and 16 mil-
lion restricted-activity days each year (10). By
reducing emissions from nine older coal plants
in the Midwest alone, it has been estimated
that roughly 300 deaths, 2,000 respiratory and
cardiac hospital admissions, 10,000 asthma
attacks, and 400,000 person-days of respira-
tory symptoms could be avoided each year
(11). Some scientists have also predicted that
reducing GHG emissions in just four major
cities (Sao Paulo, Brazil; Mexico City, Mexico;
Santiago, Chile; and New York City, USA)
could save 64,000 lives over the next 20 years
(10–12). It has been suggested that invest-
ments in modern technology and air quality
control in India and China could lead to
reductions in tropospheric ozone and black
carbon that would not only improve local
health and agricultural productivity but also
beneﬁt air quality and the global climate (5).
Numerous studies in urban areas have doc-
umented the relationship between urban
atmospheric particulate matter pollution emit-
ted by industrial/transportation combustion
processes and respiratory and heart diseases
(13–16). Less attention has been paid to the
significant risk of exposure to harmful com-
bustion by-products resulting from the indoor
use of solid fuel for cooking and heating.
Simple stoves burning solid fuel (mostly bio-
mass fuel) are used by about half of the world’s
people (17). Poor ventilation and inefficient
combustion result in signiﬁcant daily exposure
of women and young children to fine and
ultraﬁne particulate matter, carbon monoxide,
(CO), NOx, SOx, a range of volatile organic
compounds including formaldehyde, and
polycyclic organic matter (18). The World
Bank has estimated that indoor air pollution is
responsible for almost 50% of the burden of
total disease resulting from poor household
environments in developing countries (19).
Individual Susceptibility and
Predisposition
Environmental health researchers have deter-
mined that most human disease results from a
combination of environmental exposures and
genetic variation (20,21). However, it is not
fully understood why certain people develop
disease when challenged with environmental
agents and others remain healthy. Thus, a
more complete understanding of how genetic
characteristics affect the human response to
environmental exposures is needed to improve
approaches to the prevention and control of
environmentally induced diseases. Research
addressing individual susceptibility, especially
with respect to diseases resulting from expo-
sure to combustion by-products, is progress-
ing on a number of fronts, from molecular
biology to epidemiology.
Genetic variations may impact innate
immunity—the ability to launch an immune
response to toxins, microbes, and microbial
products with no previous exposure (22). This
may play a role in determining the susceptibil-
ity of an individual to an environmental expo-
sure. For example, nearly everyone is exposed
to at least low levels of environmental endo-
toxin. This biologically active lipopolysaccha-
ride (LPS) is a component of the outer
membrane of gram negative bacteria and pro-
duces airway inﬂammation when inhaled. LPS
has been associated with the development and
progression of asthma and other forms of air-
way disease (23). However, not everyone
exposed to LPS will develop airway disease. A
broad range of stable, reproducible physio-
logic responses to inhaled LPS has been docu-
mented among healthy, nonasthmatic people
(24). Researchers investigating the genetic
basis for the physiologic response to LPS have
gathered the first direct evidence that muta-
tions in a transmembrane receptor for LPS
(TLR4) are associated with decreased respon-
siveness to inhaled LPS (25). These ﬁndings
suggest that changes in the gene sequence alter
the innate ability of the host to respond to
environmental stress, as people with the
TLR4 substitutions may be more resistant to
localized forms of endotoxin-induced inﬂam-
mation (e.g., asthma) but more susceptible to
a systemic inﬂammatory response initiated or
exacerbated by LPS (e.g., gram negative infec-
tions, sepsis, and adverse outcomes).
In home and/or occupational settings, most
individuals are exposed to combustion-gener-
ated particles, but relatively few people with a
compromised respiratory or cardiovascular sys-
tem respond with increases in morbidity and
mortality. As a result, researchers suggest that
genetic factors play a major role in determining
individual susceptibility to particulate matter
(PM) exposure (26). Studies combining
genome-wide scans with microarray analysis
have provided comprehensive assessments of
adverse responses to environmental stimuli.
For example, research into individual suscepti-
bility in mice to nickel-induced acute lethal
lung injury revealed that response to this
metallic constituent of particulate matter and
cigarette smoke is controlled by a region on
mouse chromosome 6 with modifier genes
suggested on chromosomes 1, 2, and possibly
9 and 16 (27,28). These chromosomal regions
are near regions that also have been identiﬁed
as controlling the response to ozone, suggest-
ing that some of the same genes may be
involved in both responses (27). This type of
information may help clarify the role poly-
morphic variation plays in the determination
of individual response to environmental expo-
sures. Such knowledge may lead to improve-
ments in preventive medicine, successful
treatment interventions, and more effective
regulatory policies (29).
Epidemiologic studies provide insight to
aspects of individual susceptibility not directly
related to genetic variability. These studies
identify factors such as age, sex, occupation,
nutritional status, lifestyle, and coexisting
health conditions. These factors must be con-
sidered both independently and as potential
contributors to complex interactions. For
example, boilermakers were studied to evaluate
that role of occupational exposure to particu-
late matter in the development of pulmonary
and respiratory diseases. Boilermakers are rou-
tinely exposed to boiler fossil fuel ash as well as
particles and gases emitted during welding
activities. Boiler ash composition varies with
the type of fuel (oil, coal, natural gas, or trash)
and may include ﬁne particulate matter, poly-
cyclic aromatic hydrocarbons (PAHs), and
metals such as vanadium, nickel, iron, zinc,
chromium, and arsenic. As dictated by mainte-
nance and construction needs throughout the
course of a year, a boilermaker may work at a
variety of plants that burn multiple fuel types.
The results of a 2-year longitudinal study (30)
conducted to establish if exposure of boiler-
makers to particulate matter is linked to loss of
lung function suggest that working at gas, oil,
and coal-ﬁred plants is associated with adverse
effects on lung function. A short-term prospec-
tive study to assess the relationship between
continuously measured particles with an aero-
dynamic diameter (i.e., diameter of a sphere of
unit density that has aerodynamic behavior
identical to that of the particle of interest) <
2.5 µm and cardiac autonomic function in a
group of boilermakers exposed to fuel-oil ash
and metal fumes (31) revealed decreased vari-
ability in heart rate after occupational expo-
sure, indicating autonomic dysfunction. This
ﬁnding demonstrates the effects of ﬁne partic-
ulate matter on the autonomic nervous system
and may provide physiologic evidence for the
mechanism linking particulate matter and
increased morbidity and mortality.
Combustion By-Products:
Concerns and Current Research
The physical state and chemical composition of
combustion by-products vary with the type of
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bustion process, and the fuels that are burned.
Combustion by-products can include CO,
NOx, PAHs, polychlorinated dibenzo-p-diox-
ins (PCDDs) and dibenzofurans (PCDFs), par-
ticulate matter, and metals (32). Each of these
pollutants has been associated with adverse
impacts on human health, the environment, or
the global climate (33–35). Researchers and
regulators are paying particular attention to
several combustion by-products, and a wide
range of studies is being conducted to increase
our understanding of the contaminant levels,
risks of exposure, health impacts, and mecha-
nisms of disease etiology.
Particulate air pollution. Particulate air
pollution is characterized by both particle size
and chemical composition. Fine particles
[those with an aerodynamic diameter < 2.5 µm
(PM2.5)] are derived chieﬂy from combustion
processes or are formed as secondary combus-
tion particles including sulfates and nitrates
(36). Particles in the approximate size range of
0.2–0.5 µm can be transported long distances
and readily penetrate indoors, resulting in
ubiquitous exposure. Fine particles are small
enough to be breathed deeply into the lungs,
exposure is widespread, difﬁcult to avoid, and
occurs throughout the entire life. The public
health signiﬁcance of ﬁne particulate air pollu-
tion is substantial. One estimate of average
population decrease in life span due to expo-
sure to ﬁne particulate air pollution for lifelong
residents of some of the developed world’s
more polluted cites is 1–3 years (37).
Because no diagnostic test can prove
causality, epidemiologic studies are used to
evaluate the relationship between natural vari-
ability in exposure and variability in rates of
illness (38). Many acute and chronic popula-
tion-based epidemiologic studies have been
conducted, and the overall evidence indicates
a probable link between fine particulate air
pollution and adverse effects on cardiopul-
monary health, suggesting that all individuals
who are chronically exposed may ultimately
be affected (37). To investigate the physico-
chemical characteristics of particulate air pol-
lution that effect the cardiorespiratory system
and the mechanisms of action, epidemiolo-
gists examined the relationship between hos-
pital emergency room data and ambient air
monitoring data (39,40). Fine particulate
matter was fractionated to study the impacts
of sulfates, acidity, water-soluble metals,
organic matter (OM), and elemental carbon
(EC). The researchers observed a statistically
significant, positive association between car-
diac dysrhythmia and CO, coarse PM, and
EC < 2.5 µm (PM2.5 EC), as well as between
all cardiovascular diseases and CO, PM2.5 EC
and OM < 2.5 µm (PM2.5 OM). Although
covariation of many of the air quality indices
may confound such analyses, the study
provides one of the first assessments of PM
components in relation to emergency room
visits.
Relationships between exposure to fine
particles and genetic mutations have just
recently been established because epidemio-
logic studies require much longer monitoring
periods and broader monitoring of possible
end points (41). It has now been demonstrated
that each elevation of exposure to 10 µg/m3 of
ﬁne particulate air pollution is associated with
an 8% increase in lung cancer mortality and a
6% increase in cardiopulmonary mortality.
Thus, the ﬁne particle-associated risk of death
due to cancer is apparently greater than the
risk due to cardiopulmonary disease. The U.S.
Environmental Protection Agency’s (EPA)
current air standards for ﬁne particle air pollu-
tion are based on the older study of cardiopul-
monary disease and do not include the greater
risk of death due to cancer (8).
Regulatory and industry efforts to control
emissions of ﬁne particulate pollutants depend
on an accurate assessment of the relative con-
tributions of different types of emission
sources to ambient pollutant concentrations.
This assessment is based on emission invento-
ries compiled from source data and air quality
models. Research has been conducted to
improve methodologies for measuring pri-
mary emissions from a broad range of station-
ary and mobile sources and to evaluate
post-emission gas to particulate conversions
(42–44). Recent modiﬁcations of air quality
models enable scientists to monitor the fate of
particles emitted from different source types
and calculate the contributions from each
source to ambient air quality for use in the
design of emission control programs (45).
Advanced development of receptor-source
models has complemented these source-recep-
tor methods. Much of the critical work in the
advancement of fine particulate matter sam-
pling methods, development of air quality
models, and development of deﬁning source
apportionment through “ﬁngerprinting” was
conducted by the late Glen R. Cass.
Ultrafine particulate air pollution.
Scientists have documented health effects of
occupational exposure to ultrafine particles
(those with an aerodynamic diameter
< 0.1 µm) (46), but the impacts of exposure
to ultraﬁne particles in urban air from com-
bustion sources such as automobiles, natural
gas combustion, and electric engines remain
unknown. Ultraﬁne particles contribute little
to the total particulate mass in urban air but
are very high in number, reaching several
hundred thousand particles per cubic cen-
timeter. Ultraﬁne particles 20 nm in diameter
have the highest deposition efficiency in the
alveolar region of the lungs; ultraﬁne particles
can rapidly penetrate the epithelium so that
they can be detected in the interstitium of the
lung shortly after exposure (47). Because
ultrafine particles are always present in the
urban atmosphere, it is likely that they play a
role in causing acute lung injury in sensitive
parts of the population.
As a result of their small size, ultraﬁne par-
ticles have a large surface area and such parti-
cles may become coated or “enriched” with
contaminants in combustion flue gas or the
atmosphere including toxic metals (lead, cad-
mium, arsenic, chromium, and zinc), sulfur,
PAHs, partially oxidized hydrocarbons includ-
ing oxy-PAH (OPAH), and other hetero-
atom-containing species such as PCDDs and
PCDFs (48). Fine particles also stabilize bio-
logically active, organic radicals that induce
oxidative stress and DNA damage (49–51).
The combination of PM-borne, persistent
semiquinone-type radicals or organics and
metals can lead to interactions resulting in the
generation of reactive oxygen species (ROS)
and other secondary, biologically active
species. These findings represent a possible
mechanism for the genesis of cancer due to
exposure to ﬁne particulate air pollution (41).
Research with rodent models (52) indi-
cates that, per given mass, ultrafine particles
administered to the lung cause a greater
inflammatory response than larger particles
and that coagulation of ultraﬁne particles to
larger particles significantly decreases their
toxicity. The pulmonary inﬂammatory poten-
tial of ultraﬁne carbonaceous particles can be
signiﬁcantly enhanced in rodents by gaseous
co-pollutants such as ozone. In addition, sur-
face chemistry may play an important role in
ultraﬁne particle toxicity. Susceptibility to the
inflammatory effects of ultrafine particles in
rats and mice increases signiﬁcantly with age
and/or a compromised/sensitized respiratory
tract. It also appears that after deposition in
the lung, ultraﬁne particles are not efﬁciently
phagocytized by alveolar macrophages
(47,53). Translocation of ultraﬁne particles to
the liver and of ultrafine dye particles along
neurons has been documented, suggesting
that organ systems other than the lungs may
be impacted by ultraﬁne particles (54,55).
Elemental speciation of arsenic. Arsenic is
emitted into the atmosphere by combustion
processes such as coal-ﬁred power generation
plants, household use of coal fuel, burning of
vegetation, and volcanic activity (56). Arsenic
is released into the atmosphere primarily as
arsenic oxide (As2O3) and exists mainly
adsorbed on particulate matter. These particles
are dispersed by the wind and are returned to
the earth by wet or dry deposition. In well-
oxygenated water and sediments, nearly all
arsenic is present in the thermodynamically
stable pentavalent state (arsenate) (57).
The toxicity of arsenic species varies greatly
(58). Inorganic arsenic compounds are highly
toxic, with the anionic form, arsine (AsH3),
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and arsenate (As5+). Some organic arsenicals
are nontoxic to humans. As a result of this
variation, evaluation of total arsenic concentra-
tion is inadequate for estimating risk from
arsenic present in food and drinking water
supplies. Quantitative methods for assessing
speciﬁc forms of arsenic are necessary for risk
assessment studies and relative source contri-
bution estimates. Identiﬁcation and quantiﬁca-
tion of the specific forms of arsenic often
require the combination of two complemen-
tary techniques: efficient separation of the
species of interest and detection/quantitation.
Systems using liquid chromatography (LC)
followed by inductively coupled mass spec-
trometry (ICP-MS) can be used for elemental
speciation at sub-nanogram and sub-picogram
levels (59). Evaluation of the LC-ICP-MS sys-
tem for potential interferences revealed that
chloride can contribute minimally to As5+
determinations and potential chromatographic
interferences from iron could be minimized by
the addition of a chelating agent such as
EDTA, and this speciation method should sat-
isfy U.S. EPA validation requirements (60).
Metals in particulate matter. PM2.5 parti-
cles are generally attributable to emissions
derived from combustion sources and are
often coated with contaminants from com-
bustion ﬂue gas, including toxic metals (61).
Recent studies provide novel insights into the
early events in activation of signaling cascades
that lead to altered cellular function after
exposure to metals present in ambient air
PM. Exposure to combustion-derived metal
species such as As, V, and Zn is known to dis-
regulate phosphoprotein metabolism, result-
ing in the modulation of intracellular
signaling cascades and transcription factors.
Current research indicates that these PM
metals activate epidermal growth factor recep-
tor (EGFR) and increase levels of guanosine
triphosphate-bound Ras in human lung cells,
and Ras activation is required for Zn-induced
signaling (61,62). Although Zn-induced acti-
vation of Ras requires EGFR, it can still occur
in cells expressing kinase-inactive EGFR or
EGFR that is truncated or missing the regula-
tory autophosphorylation domain. In addi-
tion, phosphorylation of EGFR induced by
Zn can be inhibited by an Src inhibitor and
Src phosphorylation is markedly increased
following Zn exposure. These data suggest
that EGFR signaling by metal ions does not
occur through a direct effect on the receptor,
but is due to the activation of Src kinase.
These findings show novel mechanisms of
action by PM metals and may provide insight
relevant to the health effects of PM exposure.
Mechanisms of chromate mutagenesis.
Chromium is a widespread environmental
contaminant and a known human carcinogen
(63). In the environment, Cr exists primarily
in the trivalent [Cr(III)] and hexavalent
[Cr(VI)] forms. Compounds of Cr(VI), but
not Cr(III), have been found to be mutagenic
and carcinogenic (64). Chromate (CrO4
2–),
the major ionic form of Cr(VI), readily pene-
trates cell membranes (65).
Researchers are using shuttle vector sys-
tems in yeast, mammalian cells, and lung tis-
sue of transgenic mice to investigate the
mechanisms of chromate mutagenesis (66,67).
Chromate is reduced by glutathione, and
mutagenesis is influenced by tissue levels of
glutathione. Chromate reduction is accompa-
nied by the generation of highly reactive
Cr(V), a reactive intermediate, and reactive
oxygen intermediates which can cause DNA
damage including intra- and interchromoso-
mal deletions and base substitutions. These
results support the hypothesis that Cr-induced
mutagenesis is due to the generation of reac-
tive oxygen intermediates during the reduc-
tion of Cr(VI) by glutathione. In studies
conducted with a transgenic mouse system,
researchers noted a small but significant
increase in mutagenesis in kidney DNA in
addition to Cr impacts on lung tissues (68).
Dioxins. PCDDs and PCDFs are ubiqui-
tous environmental contaminants. Dioxins are
potent animal toxicants, and the complex mix-
ture of dioxins to which people are exposed is
characterized by the U.S. EPA as a “likely
human carcinogen” (69). These compounds
have never been produced intentionally nor
used commercially in the United States, but
are by-products of both anthropogenic and
natural combustion processes. Historically,
municipal and commercial waste incineration,
pesticide manufacture and use, and pulp and
paper processing have been believed to be the
major sources of emissions. Voluntary indus-
try actions, combined with regulatory con-
trols, have resulted in dramatic reductions
from these sources in the United States.
Currently, uncontrolled burning of residential
waste and accidental fires are thought to be
among the largest sources of PCDD/PCDF
emissions in the United States (70).
PCDD/PCDF formation in combustion
processes involves a series of complex mecha-
nisms, and speciﬁc aspects of these reactions
have been the subjects of controversy. In gen-
eral, PCDD/PCDF formation is a catalytic
reaction of carbon with oxygen and chlorine,
strongly dependent on the type and amount
of catalyst, temperature, duration of combus-
tion, and the type and amount of carbon
(71). On-going research will provide a more
complete understanding of dioxin formation
to formulate strategies to reduce emissions.
The influence of the polyvinylchloride
(PVC) content of the waste stream on the for-
mation of PCDDs/PCDFs during municipal
solid waste (MSW) combustion has been
debated over the last several years. Special
interest groups (e.g., Greenpeace and
Physicians for Social Responsibility) called for
de-emphasis on pollution controls and new
emphasis on control of the waste stream,
replacing PVC with alternative, chlorine-free
materials (72,73). A recent study demon-
strated that PCDD/PCDF formation is con-
trolled by variation in combustion conditions,
not PVC content or the amount of chlorine in
the waste (74). Research on methods to
reduce PCDD/PCDF emissions from small-
scale commercial boilers for energy recovery
and waste disposal indicates that if sufﬁcient
high-quality fuel is included in the waste
stream, dioxin/furan emissions can meet the
new European Union directives without the
need for cyclone cleaning (75).
The impacts of temperature and residence
times on PCDD/PCDF formation have also
been examined, and studies conducted in a
pilot-scale solid fuel bed reactor revealed dif-
ferent formation pathways for dioxins and
dibenzofurans. Chlorination of dibenzofurans
occurs after longer dwell times and at lower
ﬂue-gas temperatures. Nearly all of the chlo-
rine in flue gas is present as hydrogen chlo-
ride, and a catalyst is required for chlorination
to occur, suggesting that the activity of the
catalyst controls the formation rate of chlori-
nated furans. Additionally, these studies
showed that when bromine is added to the
fuel, more brominated than PCDFs are
formed (76). A separate study to investigate
the impact of increased bromine levels in a
waste stream containing flame retardants
found the majority of tetra-halogenated diox-
ins/dibenzofurans formed during combustion
were dibromo-dichloro-compounds (77).
Advanced Technologies: Applicability
to Research on Combustion 
By-Products
Questions concerning combustion by-products
that remain unanswered include speciﬁc issues
regarding formation, control, transport, fate,
exposure, and human and environmental health
impacts. Powerful new analytical methodolo-
gies, including microarray technology and nan-
otechnology, are providing novel approaches to
investigate these issues. These same advances are
also fueling the growth of new scientiﬁc disci-
plines such as genomics, proteomics, toxicoge-
nomics, and metabonomics. These new paths of
investigation have the potential to lead to infor-
mation, and new research strategies to elucidate
toxicologic mechanisms which will provide the
answers to some of the questions surrounding
the environmental health impacts of combus-
tion by-products.
Nanotechnology, the fabrication of devices
with atomic or molecular scale precision (a
nanometer is one-billionth of a meter), will
allow scientists to build biosensors using semi-
conductor, organic, and hybrid materials (78).
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rapid response time, real-time monitoring, and
the capability to analyze biologic phenomena
at the cellular level. They may reveal valuable
basic information about intracellular responses
to the toxicants in combustion by-products
and delineate the origins of their adverse health
effects. External biosensors may be capable of
monitoring emissions of combustion by-prod-
ucts using compact solid state modules.
In addition, nanotechnology is vital to the
fabrication of DNA microarrays, which are
powerful, high-throughput tools for simultane-
ously monitoring the expression of thousands
of genes or even the entire genome. In a
microarray, copies of DNA, each from a sepa-
rate gene, are printed on “platforms” which can
be glass slides, silicon chips, or nylon mem-
branes (79). After exposure to a chemical, gene
expression is assessed by measuring the binding
of mRNA to the microarray DNA. Generally
the mRNA is tagged with ﬂuorescent compo-
nents, creating patterns of ﬂuorescent dots that
reveal which genes are expressed. Microarrays
have a sensitivity and dynamic range similar to
Northern blot analyses. Microarray slide-to-
slide and spot-to-spot variability are less than
animal-to-animal variability (80), and assay
reproducibility is continually improving.
The vast data derived from studies with
microarrays are playing a critical role in the
emergence of genomics, toxicogenomics, pro-
teomics, and metabonomics. For example,
microarray technologies have provided the
tools needed to support the new scientiﬁc sub-
discipline of toxicogenomics, which combines
genomics and bioinformatics to identify and
characterize the relationships between chemical
exposure and changes in genome-wide gene
expression patterns in target cells. Microarrays
will likely be used in the immediate future to
better address a number of key toxicologic
issues, including mode of action, dose–
response relationships, chemical interactions,
and the use of gene proﬁling for hazard identi-
fication in chemical mixtures and human
exposure assessment. Genomics, toxicoge-
nomics, proteomics, and metabonomics have
the potential to change the classic risk assess-
ment paradigm. Microarray technologies will
allow scientists to move past the current focus
on stepwise identiﬁcation of single biomarkers
of exposure to a speciﬁc chemical, and charac-
terize gene proﬁles that identify multiple envi-
ronmental stressors. This knowledge will allow
us to sort out the subtleties of multiple and
cumulative exposures as well as investigate the
effects of timing, duration, and sequence of
exposures (81,82).
Genomics, toxicogenomics, proteomics,
and metabonomics will provide significant
amounts of scientiﬁc data, but this informa-
tion will be very technical and will seldom
provide unambiguous answers to legal and
ethical questions. These data are vulnerable to
misinterpretation by scientists, regulators, the
media, and the general public. It is critical
that scientists and scientiﬁc institutions make
a commitment to stress effective communica-
tion of research ﬁndings to policymakers and
the general public. It is vital to ensure that
information is presented in a fashion that is
appropriate for the audience, especially when
the information relates to risk. The general
public is frequently presented with informa-
tion that is incomplete and/or misleading. It
is critical to solicit and respond to input from
stakeholders and community members when
designing research programs. This inclusive
approach helps build social investment in
research results and the public health inter-
ventions needed to protect human and envi-
ronmental health (29,83).
In addition, DNA microarrays will be
used to rapidly classify mechanism-based tox-
icants by characteristic expression proﬁles and
also identify genes that are under similar reg-
ulatory control (84). It may be possible to use
microarrays to examine the molecular back-
ground of differences in individual suscepti-
bility to certain toxic chemical groups (80).
Although an emerging consensus suggests
that many of the complex and prevalent dis-
eases that humans develop occur as a result of
multiple biologically unique gene–gene and
gene–environment interactions, this concep-
tual framework is limited. In fact, the develop-
ment of disease in humans, environmental and
otherwise, is far more complex. Environmental
exposures affect those that are vulnerable tem-
porally (age), spatially (geographically), and by
unique circumstance (co-morbid disease,
nutritional status, and genetics). Even this par-
adigm fails to address the complex interaction
of endogenous and exogenous risks that ulti-
mately interact to cause disease. Although the
recent advances in human and molecular
genetics have provided an unparalleled oppor-
tunity to understand how genes and genetic
changes interact with environmental stimuli to
either preserve health or cause disease, without
accounting for the temporal, spatial, and other
unique components of an individual’s
microenvironment, our understanding of envi-
ronmental health will remain incomplete.
These concerns are particularly applicable to
the health consequences of combustion by-
products. Future research efforts need to
embrace the complexity involved in etiology
and pathogenesis of disease rather simply
reduce the model to an understandable, but
minimally applicable, gene–exposure–response
relationship.
Regulatory and Policy Issues Related
to Particulate Matter
Particulate matter is a criteria pollutant, which
means that national ambient air quality
standards (NAAQS) have been developed to
protect public health, public welfare, and the
environment. These standards must be
reviewed every 5 years. In 1997 the U.S. EPA
published a ﬁnal rule revising the NAAQS for
PM (8). While retaining the PM10 standard
levels, the U.S. EPA added new PM2.5 stan-
dards on the basis of epidemiologic studies that
related ambient PM concentrations to various
health effects, including premature mortality,
exacerbation of asthma, and other respiratory
tract diseases, and decreased lung function (85).
Fine particles behave entirely differently
from coarse particles and are much more difﬁ-
cult and expensive to control. Faced with the
enormous ﬁnancial implications of the 1997
NAAQS for PM2.5, the American Trucking
Associations, the U.S. Chamber of Commerce,
and other state and business groups filed a
challenge to the U.S. EPA’s action. The U.S.
Court of Appeals for the District of Columbia
Circuit struck down major elements of the
U.S. EPA’s two NAAQS standards, but the
Supreme Court upheld U.S. EPA’s authority
under the Clean Air Act to set national air
quality standards that protect the American
public from harmful effects of air pollution.
On 26 March 2002, the District of Columbia
Circuit Court rejected the remaining claims
that the U.S. EPA’s decision was arbitrary and
capricious and not supported by the evidence
(86). The implementation guideline for the
PM2.5 standards calls for completion of the sci-
entiﬁc review in 2002; designation of nonat-
tainment areas by 2005; submission of state
implementation plans by 2008; and state com-
pliance by 2017 (87).
An additional regulatory effort impacting
particulate matter emitted as a by-product of
combustion processes is the Regional Haze
Rules. According to the National Academy of
Sciences, the average visual range in most of
the western United States, including national
parks and wilderness areas, is 100–150 km
(about 60–100 miles), or about one-half to
two-thirds of the natural visual range that
would exist in the absence of air pollution. In
most of the East, including parklands, the
average visual range is less than 30 km (about
20 miles), or about one-fifth of the natural
visual range (88). The primary causes of
regional haze are sulfates, organic matter, ele-
mental carbon (soot), nitrates, and soil dust.
The Regional Haze Rules are an attempt to
tackle the combined visibility effects of
numerous pollution sources through a
regional, rather than a purely local-source,
approach. These rules require all states to make
“reasonable progress” in reducing any effect
this pollution has on visibility conditions in
class I areas and to prevent future impairment
of visibility. This regional approach calls for
the reduction of non-CO2 GHGs and is pre-
dicted to reduce emissions of key pollutants
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reductions will have a positive impact on our
climate and, just as importantly, have an
immediate impact on our quality of life (5).
Critical international efforts to minimize
or eliminate emissions of combustion 
by-products are illustrated by the 2001
Stockholm Convention on Persistent Organic
Pollutants (POPs). This agreement calls for
the elimination of production and use of all
intentionally produced POPs and for contin-
uing efforts to minimize emissions of unin-
tentionally produced POPs with the goal of
ultimate elimination. The convention
requires the establishment and maintenance
of source inventories to demonstrate continu-
ing minimization of each country’s total
emissions. The United Nations Environment
Programme is focusing efforts to ensure that
all countries compile inventories that are
complete and comparable (89). Incineration
will undoubtedly be the most widely used
method for destruction of POPs.
Ethical Issues Related to Combustion
By-Products
As governments attempt to formulate appro-
priate responses to environmental issues, they
must understand and consider a myriad of
potential legal, ethical, and social issues. They
must acknowledge that air pollution is a
global issue and that regional and transoceanic
transport of air pollutants impacts neighbors,
even in distant regions.
Environmental issues related to combus-
tion by-products must be considered from a
global public health point of view. It has been
argued that although the common perception
is that the biggest environmental problems lie
in the industrial world, from the perspective
of actual ill health, environmental health
impacts are most severe in less-developed
nations (90). In addition, the largest burdens
of environmentally related diseases (including
respiratory infections related to indoor com-
bustion of biomass fuels) in developing
nations are borne by children.
Developed nations have a variety of
approaches to address these issues in less-
developed nations. Many of the environmen-
tal health problems in the developing world
are tightly interrelated with poverty (17).
Developed countries could address these
issues by increasing efforts to enhance socioe-
conomic development, which should result in
healthier household environments (90).
Additionally, industrialized countries should
eliminate and reduce the hazards caused by
their own economic and social development
and promote new affordable technologies for
developing countries. Faced with the reality of
finite resources, it is imperative that policy-
makers focus attention on developing strategies
that will yield the greatest impact (6,90).
A series of potential legal, ethical, and
social dilemmas evolves from research
advances. This concept is illustrated by the
possibilities presented by scientific advances
in toxicogenomic research. Toxicogenomics
will enable scientists to identify genetic varia-
tions and their impacts on individual
response to environmental exposures (29).
Such information could serve as the founda-
tion for the developing strategies to prevent
and control environmentally induced dis-
eases. Alternatively, this information con-
tributes to a suite of ethical, legal, and social
challenges. Discovery that polymorphism of a
specific gene is linked to an environmental
disease could lead to discrimination or
stigmatization. Health and life insurance
companies might discriminate against indi-
viduals who carry a gene linked to a disease.
Employers might terminate or reassign work-
ers on the basis of such information. Because
some polymorphisms are more common in
certain populations than in others, it is possi-
ble that a particular type of genetic suscepti-
bility might be associated with particular
ethnic or social groups. This may threaten the
employment and insurance options available
to entire groups of people. The identiﬁcation
of a polymorphism that places an individual
at a higher risk of developing an environmen-
tal disease could result in the individual being
stigmatized as carrying a “defective gene” or
as already ill, even though an environmental
trigger is required for the development of the
associated disease and the individual may
never develop the disease (29,91,92).
Not only will policymakers have to formu-
late regulations to prevent discrimination and
protect individual privacy, they must confront
the challenges of promulgating fair and appro-
priate regulations based on new information at
increased levels of complexity. Regulators will
need to determine exposure limits, deciding if
limits should be designed to protect everyone
at the levels required to protect the most sus-
ceptible populations. They will have to address
the question of what constitutes an acceptable
risk. To address each of these issues appropri-
ately, regulators require in-depth, accurate, and
accessible scientiﬁc information.
Conclusion
Research on toxic combustion by-products
may be characterized by its complexity: the
number of agents, their interactions, their
sources and origins, and their environmental
fates. Powerful advances in technology and
models have been achieved that now allow the
study of this difﬁcult problem, a problem that
has been previously considered too complex
and onerous to be addressed in regulations for
all but a few sources and a few pollutants.
Recommendations for research focus and
direction identified during the Seventh
International Congress on Combustion By-
Products are presented below.
Recommendations for research policy
priorities are
• Interdisciplinary, coordinated activities
should be developed among the governmen-
tal agencies responsible for public health,
worker health, environmental and industrial
engineering, environmental monitoring, bio-
medical research, health policy, and respira-
tory medicine. This is needed to more
effectively target research that will reduce risks
to both human health and the environment.
• Dialog should be promoted among policy
makers, researchers, nongovernmental agen-
cies, and research sponsors to address regional
and local exposure issues. Coordinated,
multisite, multipollutant research efforts are
needed to specify and quantify the health
effects of exposures to combustion by-prod-
ucts, as they are not adequately represented
by exposure to criteria pollutants such as
ozone.
• New combustion research programs should be
designed to capitalize on the important poten-
tial synergisms between on-going international
programs including efforts to reduce green-
house gas emissions and those to reduce
health-damaging emissions from solid fuel
stoves. Such programs need to integrate the
efforts of policy makers and economists as well
as engineers, scientists, and health researchers.
• Additional attention needs to be paid to
improve development and implementation
of measurement and monitoring techniques.
Improved diagnostics could lead to smart
systems, better understanding, and efﬁcient
control/prevention strategies for better use
in public health policy decision-making.
• Policy makers should focus their attention on
the development of strategies to address the
complex issues surrounding environmental
health, speciﬁcally from the standpoint of its
ethical, legal, and social implications.
Recommendations for a research frame-
work are
• An initiative on the origin and mechanism
of genotoxicity of fine particles should be
undertaken in light of the recent epidemio-
logic evidence for the correlation of expo-
sure to airborne ﬁne particulate matter and
increased risk of lung cancer, as well as the
paucity of published research on the source
of this correlation.
• Advanced methods are needed for characteri-
zation of the bioavailability of particle-associ-
ated pollutants. Fine particles can act as
effective delivery systems for toxic chemicals,
but the bioavailability of the toxins depends
on the nature of their interaction with the
particles. Advanced methods for characteriz-
ing the nature of association and binding of
stable molecular as well as radical species
with various types of particles are essential.
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standing of mechanisms of pollutant forma-
tion and stabilization at the gas–particle
interface. Research on the rate of formation
of gaseous pollutants and precursors as well
as development of mechanisms of gas–parti-
cle interactions to form pollutants are
strongly indicated. This will require develop-
ment of more detailed mechanistic models
and methods for identifying gas-phase and
surface intermediates as well as products.
• Improved computational methods for mod-
eling gas and particle properties are needed.
Detailed reaction kinetic mechanisms of
pollutant formation and fate require accu-
rate thermochemical and reaction rate para-
meters. Development of reliable ab initio
methods of calculation of these properties
are necessary as semi-empirical methods
appear unreliable.
• Rapid microarray techniques should be
applied for assessing potential health
impacts of individual pollutants and mix-
tures. The varied and complex products
formed in combustion systems can poten-
tially induce a variety of health impacts
alone or in combination in a manner that
has previously defied characterization.
Application of the rapidly advancing field
of microarray technology to screening for
various biologic end points of individual
pollutants and mixtures should be used to
address this poorly understood but critical
component of environmental health.
• Additional research should be conducted to
increase understanding of the composition,
sources, and health impacts of ﬁne and ultra-
fine particles. Atmospheric studies should
determine the composition of ﬁne and ultra-
ﬁne particles, including nano-particles; deter-
mine the ratios of elemental carbon to
organic carbon in airborne particulate matter,
identify the main sources for ﬁne, ultraﬁne
and nano-particles, and identify alterations of
ﬁne, ultraﬁne and nano-particles by time and
by location.
• Research in toxicology should be advanced to
determine the fate of ﬁne and ultraﬁne parti-
cles during inhalation and after deposition
(dosimetry); determine translocation rates to
other extrapulmonary tissues and inﬂuence
of particle chemistry on such translocation;
evaluate specific cellular and molecular
mechanisms via both animal and in vitro
studies; develop and use compromised ani-
mal models; and to apply toxicogenomics
and proteomics in mechanistic studies.
• Epidemiology studies should include prospec-
tive cohort studies of speciﬁc compromised
people (e.g., cardiovascular diseases, respira-
tory including chronic obstructive pul-
monary disease (COPD), asthma). Clinical
studies with surrogate or concentrated
ambient particles should include the elderly
and subjects with cardiovascular disease,
asthma, and COPD, as well as include mea-
sures for endothelial dysfunction and other
vascular parameters in addition to cardiac
and respiratory end points.
• Advanced techniques are needed for specia-
tion of toxic metals. The oxidation state as
well as chemical form of metals affects their
toxicity, increasing the importance of
improved methods for speciation of metals,
especially those associated with particles and
surfaces.
• Concerted and focused efforts should be
made to fulﬁll the potential of biomarkers to
signiﬁcantly reduce the burden of exposure
and disease and to protect individuals from
the uncertainty of risk, specifically in the
area of exposure and effects of combustion
by-products.
• Efforts should be focused to develop reliable
and sufficiently widespread environmental
and health monitoring systems. This is
required both to effectively target actions to
reduce outdoor pollution and to evaluate
their effectiveness.
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